Clinical Research Directory
Browse clinical research sites, groups, and studies.
EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS
Sponsor: Pierre Fabre Dermo Cosmetique
Summary
The aim of this study is to evaluate the tolerance and efficacy of a new emollient cream specifically dedicated to the eyelid area when applied in association with tacrolimus 0.1% in subjects suffering from eyelid Atopic Dermatitis.
Official title: A RANDOMIZED COMPARATIVE SPLIT FACE STUDY TO EVALUATE THE EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH A TOPICAL CALCINEURIN INHIBITOR TREATMENT - TACROLIMUS 0.1 % - IN SUBJECTS WITH ATOPIC EYELID DERMATITIS
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
33
Start Date
2025-11-03
Completion Date
2026-01-10
Last Updated
2026-09-14
Healthy Volunteers
No
Conditions
Interventions
Tested Emollient RV5258A
Topical application of the investigational eye contour emollient on one randomized eyelid over a 2-week treatment period
tacrolimus 0.1%
Twice-daily topical application of tacrolimus 0.1% initiated 24 hours prior to study inclusion and continued over a 2-week treatment period. Tacrolimus 0.1% is considered an out-of-protocol concomitant treatment.
Locations (1)
Centrum Medyczne "Tu Się Leczy" Norwida
Gdansk, Poland, Poland